The latest on COVID-19 and Genetic Heart Conditions

Share this:

Apr 22, 2020 | Katrina Sorensen, Research Coordinator | @katrinasorensen

Pictured above is a 3D printed model of the virus that causes COVID-19 created by the 3D Anatomic Modeling Lab at Mayo Clinic. Dr. Jonathan Morris, medical director of the 3D Anatomic Modeling Lab, says the model will be used as a vital tool to drive home the seriousness of the virus. For more information, check out this article published in the Mayo Clinic News Network by Ethan Grove.

The COVID-19 pandemic situation is constantly changing and staying up-to-date on information can feel like a full-time job. Mayo Clinic's Windland Smith Rice Genetic Heart Rhythm Clinic wants to make it as easy as possible for you to find the information you need to know which is why we update our Connect page daily with the latest news articles, podcasts, scientific papers, and videos related to COVID-19 and your genetic heart disease.

Our COVID-19 tab, Video Archive tab, and our Resources tab all contain vital information on the current pandemic. Check out the latest information below:

Antimalarials widely used against COVID-19 heighten risk of cardiac arrest. How can doctors minimize the danger? is an article published by Science Magazine and the American Association for the Advancement of Science that discusses the potential risk of cardiac arrest for patients taking drugs being prescribed for the treatment of COVID-19, such as chloroquine and hydroxychloroquine.

Pediheart: Pediatric Cardiology Today is a podcast that is hosted by Dr. Robert Pass, Division Chief of Pediatric Cardiology, Co-Director of the Children's Heart Center, and Director of Pediatric Electrophysiology at the Mount Sinai Health System and Children's Hospital of Philidelphia. Listen in to Pediheart Podcast #114: Navigating the QTc Prolonging Potential of Possible Therapies for COVID-19 where Dr. Pass and Dr. Michael Ackerman review a recent guideline paper by the Mayo Clinic on how to improve the safety of potential COVID-19 therapies. Dr. Ackerman also shares his thoughts on a protocol he devises to identify "at-risk" individuals and shares his thoughts on how to consider the risks of these agents when considering their use for COVID-19 therapy.

For up-to-date information, please follow Dr. Ackerman and the Windland Smith Rice Genetic Heart Rhythm Clinic on Twitter by clicking the links below.